ALPS Medical Breakthroughs ETF
SBIO
SBIO
45 hedge funds and large institutions have $65M invested in ALPS Medical Breakthroughs ETF in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
7% more funds holding
Funds holding: 42 → 45 (+3)
4.23% more ownership
Funds ownership: 25.58% → 29.8% (+4.2%)
Holders
45
Holding in Top 10
–
Calls
$917K
Puts
$373K
Top Buyers
| 1 | +$5.76M | |
| 2 | +$5.64M | |
| 3 | +$1.49M | |
| 4 |
Morgan Stanley
New York
|
+$1.24M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.18M |
Top Sellers
| 1 | -$1.45M | |
| 2 | -$635K | |
| 3 | -$402K | |
| 4 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
-$58.2K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$28K |